ARCHIVES

Clinical Trials Approved In August 2002 By NCI

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

AACR Polls Members On Tentative Date for Annual Meeting

April 11, 2003

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

January 6, 1989

The Emergence Of The National Dialogue On Cancer, 2000-2002: Special Report

August 8, 2003

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978